Navigation Links
Fish Oil Helped Stave Off Psychosis in Study Patients

Supplements may benefit those at high risk of schizophrenia

TUESDAY, Feb. 2 (HealthDay News) -- Among people at high risk of developing schizophrenia and other psychotic disorders, fish oil may help reduce their risk, researchers have found.

The new study included 81 high-risk patients with either mild psychotic symptoms, transient psychosis or a family history of psychotic disorders, plus a decrease in daily functioning. These criteria identify people whose risk of becoming psychotic may be as high as 40 percent in a one-year period.

For 12 weeks, 41 participants were assigned to take daily fish oil capsules containing 1.2 grams of omega-3 polyunsaturated fatty acids and 40 were given a placebo. Of the 76 patients who completed the study, two (4.9 percent) in the fish oil group and 11 (27.5 percent) in the placebo group progressed to psychosis, a difference of 22.6 percent, the researchers found.

Based on these results, Dr. G. Paul Amminger of Medical University of Vienna in Austria and the Orygen Youth Health Research Center in Melbourne, Australia, and colleagues estimated that four adults would have to take fish oil with omega-3 fatty acids to prevent one of them from developing psychosis over a one-year period.

In their report, published in the February issue of the Archives of General Psychiatry, the study authors also noted that patients who took the fish oil capsules had fewer symptoms of psychosis and better functioning than those who took the placebo.

The beneficial effects of fish oil capsules with omega-3 fatty acids may result from changes in cell membranes and interactions with neurotransmitter systems in the brain, the researchers explained in a news release from the journal's publisher.

Amminger and colleagues noted that many young adults are reluctant to take antipsychotic drugs due to perceived stigma and side effects such as sexual dysfunction, metabolic changes and weight gain. Omega-3 fatty acids may offer an natural alternative.

"Long-chain omega-3 fatty polyunsaturated fatty acids reduce the risk of progression to psychotic disorder and may offer a safe and efficacious strategy for indicated prevention in young people with subthreshold psychotic states," the authors concluded.

More information

Mental Health America has more about schizophrenia.

-- Robert Preidt

SOURCE: JAMA/Archives journals, news release, Feb. 1, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. More than 6 Million Helped by Partnership for Prescription Assistance
2. Crohn's & Colitis Foundation Encourages More Virtual Event Participants: Thousands Already Helped Foundation Raise Funds for Research & Support Legislation
3. Topical Spray Helped Men With Premature Ejaculation
4. Grapefruit-Heavy Diet Helped Spur Dangerous Clot
5. Clinical Data from Plastic Surgeon in New Jersey Helped in Final Determination of 2008's Top Plastic Surgery Procedures
6. AstraZeneca Helped More Than 440,000 Patients Save $612 Million on Medicines in 2008
7. Pre-emptive treatment helped curtail skin toxicity with panitumumab
8. Elderlys restless nights helped by ancient martial art
9. Researchers who helped millions with arthritis receive prestigious Janssen Award
10. Insights on Paying for Boomers Care Needs in 20-40 Years Helped by New Report
11. First-Time Shoulder Dislocations Helped by Surgery
Post Your Comments:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology: